Efficacy and Safety of Hizikia Fusiformis Extract in Subjects Showing Erosive Gastritis

Chonbuk National University

Status: Completed

Conditions: Erosive Gastritis

Treatments: Dietary Supplement: Placebo; Dietary Supplement: Hizikia Fusiformis extract

Study type: Interventional

Funder types: Other

Identifiers

NCT01689701

PKU-EG-ECKL

Details and patient eligibility

About

The investigators performed a double-blind parallel study in a group of Subjects Showing Erosive Gastritis who were given Hizikia Fusiformis Extract over a period of 4 weeks. Endoscopic observations were performed before and 4 weeks after the treatment, and the cure and improvement rates were investigated.

Enrollment: 54 patients

Sex: All

Ages: 19 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Males and females 19-70 years old
• Subjects Showing Erosive Gastritis (endoscopy)
• Able to give informed consent

Exclusion criteria

• Diagnosed of gastrointestinal disease such as ulcer, cancer within 1 months
• Allergic or hypersensitive to any of the ingredients in the test products
• History of disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease or gastrointestinal surgery
• Taken antibiotics and stomach medicines such as steroid, bismuth compound and proton pump inhibitor within 1 months
• Participation in any other clinical trials within past 2 months
• Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
• Pregnant or lactating women etc.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

54 participants in 2 patient groups, including a placebo group

Hizikia Fusiformis extract

Experimental group

Treatment:

Dietary Supplement: Hizikia Fusiformis extract

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: Placebo